Friday, 14 August 2026Madrid 38°/ 24°Petrol

Breaking

Madrid allocates €18.5 million for 170,000 RSV vaccines for the elderly

Madrid will invest €18.5 million in RSV vaccines for those over 80 years old.

Ernesto TafallaErnesto Tafalla· · 3 min read

The Community of Madrid will invest in the purchase of vaccines against RSV to protect those over 80 years old. This measure aims to increase immunisation against severe respiratory diseases.

The Community of Madrid has decided to take a significant step in protecting its most vulnerable citizens by announcing an investment of €18.5 million to acquire 170,000 doses of vaccine against respiratory syncytial virus (RSV). This decision was approved in the last Governing Council and represents a notable increase, with 70,000 more doses than the previous year, raising the resources allocated to this crucial immunisation by 50%.

RSV is known for causing severe respiratory illnesses, such as bronchiolitis and pneumonia, especially among the elderly. With this new campaign, Madrid aims to protect those over 80 years old, who are part of the group most affected by this virus. Vaccination was officially introduced in 2026 after having previously started immunisation for vulnerable adults and residents in social health centres from 2025.

From September last year to June of the current year, 154,237 doses were administered to the adult population in Madrid's health centres, achieving an approximate coverage of 30% among those over 80 years old who are part of the target group.

The decision to expand vaccination to this age group is based on the positive results obtained from vaccinating infants under one year old during the 2023/2024 season. According to data provided by the regional government, this strategy reduced hospital admissions related to RSV in that population segment by approximately 90%.

The positive impact observed has led Madrid's health authorities to consider it essential to continue with these preventive measures to protect not only the elderly but also the healthcare system as a whole. The RSV vaccine requires a single dose and can be administered throughout the year, facilitating its implementation and access for those who need it most.

With this initiative, Madrid positions itself as a proactive region against the threats posed by seasonal respiratory diseases. The community hopes that this expansion will not only improve public health but also alleviate pressure on hospitals and medical services during the critical months of the year.

Interested citizens can find out how to access these vaccines by contacting their local health centres or consulting the official website of the Madrid Health Service. The campaign is designed to be accessible and effective, ensuring that all elderly individuals who need protection can receive it without complications.

Ernesto Tafalla

Written by

Ernesto Tafalla